QA: Marinus Pharmaceuticals INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267813_2024_Marinus_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Large missing amount for aggregate "Revenues" added to remainder. industry.us_generic {'missing_ratio': 1.7245472129417971, 'aggregate_val': 30989000, 'exp_sum': 11374000, 'exp_to_value': {'remainder_Revenues': 11374000}}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS': 15, '00205 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOS) - Calc2': 2}}

Graph

Absolute values for 0001267813, Marinus Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 165,246,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,843,000
3 remainder_Assets 1,819,000
4 LiabilitiesCurrent 40,624,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 113,519,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 64,732,567
9 ResearchAndDevelopmentExpense 101,774,203
10 remainder_Expenses 18,054,034
11 remainder_Revenues 39,297,389
12 remainder_NetIncome 54,372,599
13 remainder_ComprehensiveNetIncome -20,000
  yvar yval
0 Assets 170,908,000
1 Liabilities 154,143,000
2 Expenses 184,560,804
3 Revenues 39,297,389
4 StockholdersEquity 16,765,000
5 NetIncome -90,890,816
6 ComprehensiveNetIncome -90,900,816
7 BaseVar 301,650,896
8 EconomicCapitalRatiobeforeLimitedLiability -0.334
9 EconomicCapitalRatio 1.40

Edgar->Model Mapping

Feature Distribution

Change over Time